James Hippel

2019

In 2019, James Hippel earned a total compensation of $2.8M as Senior Vice President of Finance and CFO at Bio-Techne, a 13% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$634,254
Option Awards$1,200,090
Salary$514,188
Stock Awards$399,916
Other$9,342
Total$2,757,790

Hippel received $1.2M in option awards, accounting for 44% of the total pay in 2019.

Hippel also received $634.3K in non-equity incentive plan, $514.2K in salary, $399.9K in stock awards and $9.3K in other compensation.

Rankings

In 2019, James Hippel's compensation ranked 4,426th out of 13,971 executives tracked by ExecPay. In other words, Hippel earned more than 68.3% of executives.

ClassificationRankingPercentile
All
4,426
out of 13,971
68th
Division
Manufacturing
1,638
out of 5,701
71st
Major group
Chemicals And Allied Products
575
out of 2,200
74th
Industry group
Drugs
484
out of 1,886
74th
Industry
Biological Products, Except Diagnostic Substances
105
out of 389
73rd
Source: SEC filing on September 9, 2019.

Hippel's colleagues

We found four more compensation records of executives who worked with James Hippel at Bio-Techne in 2019.

2019

Charles Kummeth

Bio-Techne

Chief Executive Officer

2019

David Eansor

Bio-Techne

Senior Vice President Biotechnology

2019

Kim Kelderman

Bio-Techne

President, Diagnostics and Genomics

2019

Brenda Furlow

Bio-Techne

General Counsel

News

You may also like